Bi1 Procare is positioned as the most suitable diet for the oncological patient by adapting to the guidelines ESPEN 2017 and SEOM 2019
This was shown at the II Conference on Nutrition for oncology nursing held in Lerma (Burgos)
On March 23, Adventia organized a training session for oncology nursing on updating detection, diagnosis and treatment of malnutrition in the oncology patient in Lerma (Burgos).
The main objective of the day was to carry out an update and training on malnutrition of the oncological patient. Its prevalence and clinical repercussion, its early detection through nutritional screening, its diagnosis through the GLIM 2018 criteria, as well as the selection of the most appropriate nutritional treatment (discarding those that are not specific and do not meet the recommendations for cancer patients). ), were the key points of this day.
In this framework, Bi1 Procare was shown as the most appropriate diet for the oncological patient, since it conforms to the Clinical Guidelines of Nutrition in Oncological Patient of ESPEN 2017 (European Society for Clinical Nutrition and Metabolism) and of SEOM 2019 (Spanish Society of Medical Oncology).
The Clinical Guidelines on Nutrition in the Oncology Patient of ESPEN 2017 and SEOM 2019 recommend hypercaloric and hyperproteic formulas with low carbohydrate content and an adequate content of EPA and DHA. Bi1 Procare has been designed and formulated following these recommendations and covers the nutritional needs of the cancer patient at any stage of his disease and antineoplastic treatment that receives chemotherapy, radiotherapy or surgery.
The speaker, Dr. Alicia Calleja, stressed the importance of the detection and early and specific treatment of malnutrition in cancer patients: "ensuring an adequate nutritional status of cancer patients is a key aspect to improve tolerance to antineoplastic treatments, improve their quality of life and increase their survival ".